Search research articles
Contact Us
Filters
Showing results (1-10 of 303) with videos related to
Page
of 31
Sort By:
Immunology and Allergy Clinics of North America
|
April 26, 2022
Drug Hypersensitivity: A Glass Half Full
Elizabeth J Phillips
Clinical Pharmacology and Therapeutics
|
August 19, 2018
Defining Regional Differences in Drug-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Tool to Improve Drug Safety?
Elizabeth J Phillips
British Journal of Clinical Pharmacology
|
August 20, 2015
Classifying ADRs--does dose matter?
Elizabeth J Phillips
Current Opinion in HIV and AIDS
|
April 18, 2009
The pharmacogenetics of antiretroviral therapy
Elizabeth J Phillips
ACP Journal Club
|
March 5, 2002
Itraconazole was as effective as amphotericin B for fever and neutropenia in cancer and led to fewer adverse events
Elizabeth J Phillips
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 8, 2006
Genetic screening to prevent abacavir hypersensitivity reaction: are we there yet?
Elizabeth J Phillips
Transactions of the American Clinical and Climatological Association
|
September 1, 2018
NEW STRATEGIES TO PREDICT AND PREVENT SERIOUS IMMUNOLOGICALLY MEDIATED ADVERSE DRUG REACTIONS
Elizabeth J Phillips
JAMA Network Open
|
August 31, 2021
Allergic Reactions After COVID-19 Vaccination-Putting Risk Into Perspective
Elizabeth J Phillips
The Journal of Allergy and Clinical Immunology. in Practice
|
March 28, 2024
A New Year, A New Era in Drug Hypersensitivity-Looking Beyond the Classical Paradigms
Rik Schrijvers, Elizabeth J Phillips
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique
|
November 8, 2002
The chronicles of HIV therapeutics: where to begin, when to start and how will it end--a tale of two decades and beyond?
Elizabeth J Phillips, Alice Tseng
Page
of 31
Search research articles
Search
Showing results (1-10 of 303) with videos related to
Sort By:
Page
of 31
Immunology and Allergy Clinics of North America
|
April 26, 2022
Drug Hypersensitivity: A Glass Half Full
Elizabeth J Phillips
Clinical Pharmacology and Therapeutics
|
August 19, 2018
Defining Regional Differences in Drug-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Tool to Improve Drug Safety?
Elizabeth J Phillips
British Journal of Clinical Pharmacology
|
August 20, 2015
Classifying ADRs--does dose matter?
Elizabeth J Phillips
Current Opinion in HIV and AIDS
|
April 18, 2009
The pharmacogenetics of antiretroviral therapy
Elizabeth J Phillips
ACP Journal Club
|
March 5, 2002
Itraconazole was as effective as amphotericin B for fever and neutropenia in cancer and led to fewer adverse events
Elizabeth J Phillips
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 8, 2006
Genetic screening to prevent abacavir hypersensitivity reaction: are we there yet?
Elizabeth J Phillips
Transactions of the American Clinical and Climatological Association
|
September 1, 2018
NEW STRATEGIES TO PREDICT AND PREVENT SERIOUS IMMUNOLOGICALLY MEDIATED ADVERSE DRUG REACTIONS
Elizabeth J Phillips
JAMA Network Open
|
August 31, 2021
Allergic Reactions After COVID-19 Vaccination-Putting Risk Into Perspective
Elizabeth J Phillips
The Journal of Allergy and Clinical Immunology. in Practice
|
March 28, 2024
A New Year, A New Era in Drug Hypersensitivity-Looking Beyond the Classical Paradigms
Rik Schrijvers, Elizabeth J Phillips
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique
|
November 8, 2002
The chronicles of HIV therapeutics: where to begin, when to start and how will it end--a tale of two decades and beyond?
Elizabeth J Phillips, Alice Tseng
Page
of 31